Celcuity LLC (CELC)
Healthcare
Biotechnology
87.70 $
+1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Celcuity LLC (CELC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -55 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.7 | -13 | -19 | -17 | -18 | -21 | -28 | -36 | -36 | -45 | -36 | -55 | -172 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| 1.3 | 1.1 | 1.2 | 1.3 | 1.4 | 1.9 | 2.3 | 2.4 | 2.7 | 6.8 | 9.5 | 5.3 | 24 | |
| 1.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.4 | 4.5 | -0.9 | 2.8 | 4.1 | 7.0 | 4.5 | -1.2 | 4.2 | -7.7 | 2.0 | -8.3 | -9.7 | |
| 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.4 | |
| 8.1 | 6.3 | -41 | 3.5 | -106 | 1.9 | 38 | 24 | 66 | -258 | 103 | 35 | -54 | |
| 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | – | – | – | – | 0.0 | -7.4 | – | – | 223 | -0.5 | – | – | |
| 0.2 | 0.0 | 65 | 14 | 123 | 0.8 | 0.1 | 5.6 | 0.2 | 330 | 24 | 0.0 | 355 | |
| -1.4 | -6.5 | 4.9 | 0.6 | -0.8 | -18 | 9.9 | -6.0 | 30 | 28 | 91 | -21 | 129 | |
| -9.7 | -13 | -19 | -17 | -18 | -21 | -28 | -36 | -36 | -45 | -36 | -55 | -173 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.